Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
12,214
archived clinical trials in
Women's Studies

Cisplatin and Radiation Therapy With or Without Triapine in Treating Patients With Previously Untreated Stage IB-IVA Cervical Cancer or Stage II-IVA Vaginal Cancer
Randomized Phase II Study of Intravenous 3-Aminopyridine-2-Carboxaldehyde Thiosemicarbazone (3-AP, Triapine® NSC #663249) Cisplatin-Radiochemotherapy Versus Intravenous Cisplatin-Radiochemotherapy in Women Diagnosed With Stage IB-IVA Cervical Cancer and Stage II-IVA Vaginal Cancer
Status: Enrolling
Updated:  3/25/2016
Moffitt Cancer Center
2134
mi
from 91732
Tampa, FL
Cisplatin and Radiation Therapy With or Without Triapine in Treating Patients With Previously Untreated Stage IB-IVA Cervical Cancer or Stage II-IVA Vaginal Cancer
Randomized Phase II Study of Intravenous 3-Aminopyridine-2-Carboxaldehyde Thiosemicarbazone (3-AP, Triapine® NSC #663249) Cisplatin-Radiochemotherapy Versus Intravenous Cisplatin-Radiochemotherapy in Women Diagnosed With Stage IB-IVA Cervical Cancer and Stage II-IVA Vaginal Cancer
Status: Enrolling
Updated: 3/25/2016
Moffitt Cancer Center
2134
mi
from 91732
Tampa, FL
Click here to add this to my saved trials
Cisplatin and Radiation Therapy With or Without Triapine in Treating Patients With Previously Untreated Stage IB-IVA Cervical Cancer or Stage II-IVA Vaginal Cancer
Randomized Phase II Study of Intravenous 3-Aminopyridine-2-Carboxaldehyde Thiosemicarbazone (3-AP, Triapine® NSC #663249) Cisplatin-Radiochemotherapy Versus Intravenous Cisplatin-Radiochemotherapy in Women Diagnosed With Stage IB-IVA Cervical Cancer and Stage II-IVA Vaginal Cancer
Status: Enrolling
Updated:  3/25/2016
Summa Akron City Hospital/Cooper Cancer Center
2041
mi
from 91732
Akron, OH
Cisplatin and Radiation Therapy With or Without Triapine in Treating Patients With Previously Untreated Stage IB-IVA Cervical Cancer or Stage II-IVA Vaginal Cancer
Randomized Phase II Study of Intravenous 3-Aminopyridine-2-Carboxaldehyde Thiosemicarbazone (3-AP, Triapine® NSC #663249) Cisplatin-Radiochemotherapy Versus Intravenous Cisplatin-Radiochemotherapy in Women Diagnosed With Stage IB-IVA Cervical Cancer and Stage II-IVA Vaginal Cancer
Status: Enrolling
Updated: 3/25/2016
Summa Akron City Hospital/Cooper Cancer Center
2041
mi
from 91732
Akron, OH
Click here to add this to my saved trials
Family Nurture Intervention in the CHoNJ NICU
Randomized Control Trial of Family Nurture Intervention in the Children's Hospital of New Jersey Neonatal Intensive Care Unit
Status: Enrolling
Updated:  3/25/2016
Children's Hospital of New Jersey
2424
mi
from 91732
Newark, NJ
Family Nurture Intervention in the CHoNJ NICU
Randomized Control Trial of Family Nurture Intervention in the Children's Hospital of New Jersey Neonatal Intensive Care Unit
Status: Enrolling
Updated: 3/25/2016
Children's Hospital of New Jersey
2424
mi
from 91732
Newark, NJ
Click here to add this to my saved trials
Family Nurture Intervention in the CHoNJ NICU
Randomized Control Trial of Family Nurture Intervention in the Children's Hospital of New Jersey Neonatal Intensive Care Unit
Status: Enrolling
Updated:  3/25/2016
Columbia University Data Coordinating Center
2351
mi
from 91732
New York, NY
Family Nurture Intervention in the CHoNJ NICU
Randomized Control Trial of Family Nurture Intervention in the Children's Hospital of New Jersey Neonatal Intensive Care Unit
Status: Enrolling
Updated: 3/25/2016
Columbia University Data Coordinating Center
2351
mi
from 91732
New York, NY
Click here to add this to my saved trials
Early Detection of Ovarian Cancer: GC/FT-ICR Mass Spectrometry and Canine Olfaction
Early Detection of Epithelial Ovarian Cancer Using Exhaled Breath Markers: GC/FT-ICR Mass Spectrometry and Canine Olfaction.
Status: Enrolling
Updated:  3/28/2016
Pine Street Foundation
370
mi
from 91732
San Anselmo, CA
Early Detection of Ovarian Cancer: GC/FT-ICR Mass Spectrometry and Canine Olfaction
Early Detection of Epithelial Ovarian Cancer Using Exhaled Breath Markers: GC/FT-ICR Mass Spectrometry and Canine Olfaction.
Status: Enrolling
Updated: 3/28/2016
Pine Street Foundation
370
mi
from 91732
San Anselmo, CA
Click here to add this to my saved trials
Early Detection of Ovarian Cancer: GC/FT-ICR Mass Spectrometry and Canine Olfaction
Early Detection of Epithelial Ovarian Cancer Using Exhaled Breath Markers: GC/FT-ICR Mass Spectrometry and Canine Olfaction.
Status: Enrolling
Updated:  3/28/2016
UCSF Helen Diller Family Comprehensive Cancer Center
356
mi
from 91732
San Francisco, CA
Early Detection of Ovarian Cancer: GC/FT-ICR Mass Spectrometry and Canine Olfaction
Early Detection of Epithelial Ovarian Cancer Using Exhaled Breath Markers: GC/FT-ICR Mass Spectrometry and Canine Olfaction.
Status: Enrolling
Updated: 3/28/2016
UCSF Helen Diller Family Comprehensive Cancer Center
356
mi
from 91732
San Francisco, CA
Click here to add this to my saved trials
Early Detection of Ovarian Cancer: GC/FT-ICR Mass Spectrometry and Canine Olfaction
Early Detection of Epithelial Ovarian Cancer Using Exhaled Breath Markers: GC/FT-ICR Mass Spectrometry and Canine Olfaction.
Status: Enrolling
Updated:  3/28/2016
California Pacific Medical Center - California Campus
357
mi
from 91732
San Francisco, CA
Early Detection of Ovarian Cancer: GC/FT-ICR Mass Spectrometry and Canine Olfaction
Early Detection of Epithelial Ovarian Cancer Using Exhaled Breath Markers: GC/FT-ICR Mass Spectrometry and Canine Olfaction.
Status: Enrolling
Updated: 3/28/2016
California Pacific Medical Center - California Campus
357
mi
from 91732
San Francisco, CA
Click here to add this to my saved trials
Early Detection of Ovarian Cancer: GC/FT-ICR Mass Spectrometry and Canine Olfaction
Early Detection of Epithelial Ovarian Cancer Using Exhaled Breath Markers: GC/FT-ICR Mass Spectrometry and Canine Olfaction.
Status: Enrolling
Updated:  3/28/2016
University of Maine
2690
mi
from 91732
Orono, ME
Early Detection of Ovarian Cancer: GC/FT-ICR Mass Spectrometry and Canine Olfaction
Early Detection of Epithelial Ovarian Cancer Using Exhaled Breath Markers: GC/FT-ICR Mass Spectrometry and Canine Olfaction.
Status: Enrolling
Updated: 3/28/2016
University of Maine
2690
mi
from 91732
Orono, ME
Click here to add this to my saved trials
Nurse Family Partnership (NFP) Contraceptive Study
Effectiveness of Home Based Distribution of Hormonal Contraceptives for Women at Risk for Unintended Pregnancy
Status: Enrolling
Updated:  3/28/2016
Thurston County Public Health
932
mi
from 91732
Olympia, WA
Nurse Family Partnership (NFP) Contraceptive Study
Effectiveness of Home Based Distribution of Hormonal Contraceptives for Women at Risk for Unintended Pregnancy
Status: Enrolling
Updated: 3/28/2016
Thurston County Public Health
932
mi
from 91732
Olympia, WA
Click here to add this to my saved trials
Nurse Family Partnership (NFP) Contraceptive Study
Effectiveness of Home Based Distribution of Hormonal Contraceptives for Women at Risk for Unintended Pregnancy
Status: Enrolling
Updated:  3/28/2016
Seattle - King County Public Health
961
mi
from 91732
Seattle, WA
Nurse Family Partnership (NFP) Contraceptive Study
Effectiveness of Home Based Distribution of Hormonal Contraceptives for Women at Risk for Unintended Pregnancy
Status: Enrolling
Updated: 3/28/2016
Seattle - King County Public Health
961
mi
from 91732
Seattle, WA
Click here to add this to my saved trials
Nurse Family Partnership (NFP) Contraceptive Study
Effectiveness of Home Based Distribution of Hormonal Contraceptives for Women at Risk for Unintended Pregnancy
Status: Enrolling
Updated:  3/28/2016
Clark County Public Health
844
mi
from 91732
Vancouver, WA
Nurse Family Partnership (NFP) Contraceptive Study
Effectiveness of Home Based Distribution of Hormonal Contraceptives for Women at Risk for Unintended Pregnancy
Status: Enrolling
Updated: 3/28/2016
Clark County Public Health
844
mi
from 91732
Vancouver, WA
Click here to add this to my saved trials
Prematurity and Respiratory Outcomes Program (PROP)
Prematurity and Respiratory Outcomes Program (PROP) Core Database Protocol
Status: Enrolling
Updated:  3/28/2016
Alta Bates Summit Medical Center
350
mi
from 91732
Oakland, CA
Prematurity and Respiratory Outcomes Program (PROP)
Prematurity and Respiratory Outcomes Program (PROP) Core Database Protocol
Status: Enrolling
Updated: 3/28/2016
Alta Bates Summit Medical Center
350
mi
from 91732
Oakland, CA
Click here to add this to my saved trials
Prematurity and Respiratory Outcomes Program (PROP)
Prematurity and Respiratory Outcomes Program (PROP) Core Database Protocol
Status: Enrolling
Updated:  3/28/2016
Indiana University Health/Riley Hospital for Children
1793
mi
from 91732
Indianapolis, IN
Prematurity and Respiratory Outcomes Program (PROP)
Prematurity and Respiratory Outcomes Program (PROP) Core Database Protocol
Status: Enrolling
Updated: 3/28/2016
Indiana University Health/Riley Hospital for Children
1793
mi
from 91732
Indianapolis, IN
Click here to add this to my saved trials
Prematurity and Respiratory Outcomes Program (PROP)
Prematurity and Respiratory Outcomes Program (PROP) Core Database Protocol
Status: Enrolling
Updated:  3/28/2016
Washington Universitiy
1573
mi
from 91732
St Louis, MO
Prematurity and Respiratory Outcomes Program (PROP)
Prematurity and Respiratory Outcomes Program (PROP) Core Database Protocol
Status: Enrolling
Updated: 3/28/2016
Washington Universitiy
1573
mi
from 91732
St Louis, MO
Click here to add this to my saved trials
Prematurity and Respiratory Outcomes Program (PROP)
Prematurity and Respiratory Outcomes Program (PROP) Core Database Protocol
Status: Enrolling
Updated:  3/28/2016
University at Buffalo
2184
mi
from 91732
Buffalo, NY
Prematurity and Respiratory Outcomes Program (PROP)
Prematurity and Respiratory Outcomes Program (PROP) Core Database Protocol
Status: Enrolling
Updated: 3/28/2016
University at Buffalo
2184
mi
from 91732
Buffalo, NY
Click here to add this to my saved trials
Prematurity and Respiratory Outcomes Program (PROP)
Prematurity and Respiratory Outcomes Program (PROP) Core Database Protocol
Status: Enrolling
Updated:  3/28/2016
University of Rochester
2244
mi
from 91732
Rochester, NY
Prematurity and Respiratory Outcomes Program (PROP)
Prematurity and Respiratory Outcomes Program (PROP) Core Database Protocol
Status: Enrolling
Updated: 3/28/2016
University of Rochester
2244
mi
from 91732
Rochester, NY
Click here to add this to my saved trials
Prematurity and Respiratory Outcomes Program (PROP)
Prematurity and Respiratory Outcomes Program (PROP) Core Database Protocol
Status: Enrolling
Updated:  3/28/2016
Duke Univ Med Ctr
2203
mi
from 91732
Durham, NC
Prematurity and Respiratory Outcomes Program (PROP)
Prematurity and Respiratory Outcomes Program (PROP) Core Database Protocol
Status: Enrolling
Updated: 3/28/2016
Duke Univ Med Ctr
2203
mi
from 91732
Durham, NC
Click here to add this to my saved trials
Prematurity and Respiratory Outcomes Program (PROP)
Prematurity and Respiratory Outcomes Program (PROP) Core Database Protocol
Status: Enrolling
Updated:  3/28/2016
Cincinnati University Hospital
1880
mi
from 91732
Cincinnati, OH
Prematurity and Respiratory Outcomes Program (PROP)
Prematurity and Respiratory Outcomes Program (PROP) Core Database Protocol
Status: Enrolling
Updated: 3/28/2016
Cincinnati University Hospital
1880
mi
from 91732
Cincinnati, OH
Click here to add this to my saved trials
Prematurity and Respiratory Outcomes Program (PROP)
Prematurity and Respiratory Outcomes Program (PROP) Core Database Protocol
Status: Enrolling
Updated:  3/28/2016
Good Samaritan Hospital
1879
mi
from 91732
Cincinnati, OH
Prematurity and Respiratory Outcomes Program (PROP)
Prematurity and Respiratory Outcomes Program (PROP) Core Database Protocol
Status: Enrolling
Updated: 3/28/2016
Good Samaritan Hospital
1879
mi
from 91732
Cincinnati, OH
Click here to add this to my saved trials
Prematurity and Respiratory Outcomes Program (PROP)
Prematurity and Respiratory Outcomes Program (PROP) Core Database Protocol
Status: Enrolling
Updated:  3/28/2016
Jackson Madison County General Hospital
1653
mi
from 91732
Jackson, TN
Prematurity and Respiratory Outcomes Program (PROP)
Prematurity and Respiratory Outcomes Program (PROP) Core Database Protocol
Status: Enrolling
Updated: 3/28/2016
Jackson Madison County General Hospital
1653
mi
from 91732
Jackson, TN
Click here to add this to my saved trials
Prematurity and Respiratory Outcomes Program (PROP)
Prematurity and Respiratory Outcomes Program (PROP) Core Database Protocol
Status: Enrolling
Updated:  3/28/2016
Monroe Carell Jr. Children's Hospital at Vanderbilt
1763
mi
from 91732
Nashville, TN
Prematurity and Respiratory Outcomes Program (PROP)
Prematurity and Respiratory Outcomes Program (PROP) Core Database Protocol
Status: Enrolling
Updated: 3/28/2016
Monroe Carell Jr. Children's Hospital at Vanderbilt
1763
mi
from 91732
Nashville, TN
Click here to add this to my saved trials
Prematurity and Respiratory Outcomes Program (PROP)
Prematurity and Respiratory Outcomes Program (PROP) Core Database Protocol
Status: Enrolling
Updated:  3/28/2016
University of California at San Francisco
356
mi
from 91732
San Francisco, CA
Prematurity and Respiratory Outcomes Program (PROP)
Prematurity and Respiratory Outcomes Program (PROP) Core Database Protocol
Status: Enrolling
Updated: 3/28/2016
University of California at San Francisco
356
mi
from 91732
San Francisco, CA
Click here to add this to my saved trials
Prematurity and Respiratory Outcomes Program (PROP)
Prematurity and Respiratory Outcomes Program (PROP) Core Database Protocol
Status: Enrolling
Updated:  3/28/2016
Cincinnati Children's Hospital
1880
mi
from 91732
Cincinnati, OH
Prematurity and Respiratory Outcomes Program (PROP)
Prematurity and Respiratory Outcomes Program (PROP) Core Database Protocol
Status: Enrolling
Updated: 3/28/2016
Cincinnati Children's Hospital
1880
mi
from 91732
Cincinnati, OH
Click here to add this to my saved trials
Prematurity and Respiratory Outcomes Program (PROP)
Prematurity and Respiratory Outcomes Program (PROP) Core Database Protocol
Status: Enrolling
Updated:  3/28/2016
The University of Texas, Houston
1357
mi
from 91732
Houston, TX
Prematurity and Respiratory Outcomes Program (PROP)
Prematurity and Respiratory Outcomes Program (PROP) Core Database Protocol
Status: Enrolling
Updated: 3/28/2016
The University of Texas, Houston
1357
mi
from 91732
Houston, TX
Click here to add this to my saved trials
A Mixed-Methods Approach to Understanding Factors Associated With Cervical Cancer Screening Utilization Among Low-Income, HIV-Positive Women
A Mixed-Methods Approach to Understanding Factors Associated With Cervical Cancer Screening Utilization Among Low-Income, HIV-Positive Women
Status: Enrolling
Updated:  3/28/2016
Thomas Street Health Center, Harris County Hospital District
1357
mi
from 91732
Houston, TX
A Mixed-Methods Approach to Understanding Factors Associated With Cervical Cancer Screening Utilization Among Low-Income, HIV-Positive Women
A Mixed-Methods Approach to Understanding Factors Associated With Cervical Cancer Screening Utilization Among Low-Income, HIV-Positive Women
Status: Enrolling
Updated: 3/28/2016
Thomas Street Health Center, Harris County Hospital District
1357
mi
from 91732
Houston, TX
Click here to add this to my saved trials
Tamoxifen for the Treatment of Unfavorable Bleeding in Contraceptive Implant Users
Tamoxifen for the Treatment of Unfavorable Bleeding Patterns in Etonogestrel Contraceptive Implant Users
Status: Enrolling
Updated:  3/28/2016
Oregon Health & Science University (OHSU)
826
mi
from 91732
Portland, OR
Tamoxifen for the Treatment of Unfavorable Bleeding in Contraceptive Implant Users
Tamoxifen for the Treatment of Unfavorable Bleeding Patterns in Etonogestrel Contraceptive Implant Users
Status: Enrolling
Updated: 3/28/2016
Oregon Health & Science University (OHSU)
826
mi
from 91732
Portland, OR
Click here to add this to my saved trials
Lifestyle and Fertility Study on Antioxidant Status, Diet and Early Pregnancy
Antioxidant Status, Diet and Early Pregnancy
Status: Enrolling
Updated:  3/30/2016
Dartmouth Hitchcock Medical Center
2515
mi
from 91732
Lebanon, NH
Lifestyle and Fertility Study on Antioxidant Status, Diet and Early Pregnancy
Antioxidant Status, Diet and Early Pregnancy
Status: Enrolling
Updated: 3/30/2016
Dartmouth Hitchcock Medical Center
2515
mi
from 91732
Lebanon, NH
Click here to add this to my saved trials
Lifestyle and Fertility Study on Antioxidant Status, Diet and Early Pregnancy
Antioxidant Status, Diet and Early Pregnancy
Status: Enrolling
Updated:  3/30/2016
Penn State University
2230
mi
from 91732
University Park, PA
Lifestyle and Fertility Study on Antioxidant Status, Diet and Early Pregnancy
Antioxidant Status, Diet and Early Pregnancy
Status: Enrolling
Updated: 3/30/2016
Penn State University
2230
mi
from 91732
University Park, PA
Click here to add this to my saved trials
Study of Effectiveness and Safety of Azithromycin-based Extended-spectrum Prophylaxis to Prevent Post Cesarean Infection
Cesarean Section Optimal Antibiotic Prophylaxis Trial
Status: Enrolling
Updated:  4/1/2016
University of Alabama at Birmingham
1777
mi
from 91732
Birmingham, AL
Study of Effectiveness and Safety of Azithromycin-based Extended-spectrum Prophylaxis to Prevent Post Cesarean Infection
Cesarean Section Optimal Antibiotic Prophylaxis Trial
Status: Enrolling
Updated: 4/1/2016
University of Alabama at Birmingham
1777
mi
from 91732
Birmingham, AL
Click here to add this to my saved trials
Study of Effectiveness and Safety of Azithromycin-based Extended-spectrum Prophylaxis to Prevent Post Cesarean Infection
Cesarean Section Optimal Antibiotic Prophylaxis Trial
Status: Enrolling
Updated:  4/1/2016
University of Mississippi Medical Center
1609
mi
from 91732
Jackson, MS
Study of Effectiveness and Safety of Azithromycin-based Extended-spectrum Prophylaxis to Prevent Post Cesarean Infection
Cesarean Section Optimal Antibiotic Prophylaxis Trial
Status: Enrolling
Updated: 4/1/2016
University of Mississippi Medical Center
1609
mi
from 91732
Jackson, MS
Click here to add this to my saved trials
Study of Effectiveness and Safety of Azithromycin-based Extended-spectrum Prophylaxis to Prevent Post Cesarean Infection
Cesarean Section Optimal Antibiotic Prophylaxis Trial
Status: Enrolling
Updated:  4/1/2016
Columbia University
2435
mi
from 91732
New York, NY
Study of Effectiveness and Safety of Azithromycin-based Extended-spectrum Prophylaxis to Prevent Post Cesarean Infection
Cesarean Section Optimal Antibiotic Prophylaxis Trial
Status: Enrolling
Updated: 4/1/2016
Columbia University
2435
mi
from 91732
New York, NY
Click here to add this to my saved trials
Study of Effectiveness and Safety of Azithromycin-based Extended-spectrum Prophylaxis to Prevent Post Cesarean Infection
Cesarean Section Optimal Antibiotic Prophylaxis Trial
Status: Enrolling
Updated:  4/1/2016
Mission Hospital
2003
mi
from 91732
Ashville, NC
Study of Effectiveness and Safety of Azithromycin-based Extended-spectrum Prophylaxis to Prevent Post Cesarean Infection
Cesarean Section Optimal Antibiotic Prophylaxis Trial
Status: Enrolling
Updated: 4/1/2016
Mission Hospital
2003
mi
from 91732
Ashville, NC
Click here to add this to my saved trials
Study of Effectiveness and Safety of Azithromycin-based Extended-spectrum Prophylaxis to Prevent Post Cesarean Infection
Cesarean Section Optimal Antibiotic Prophylaxis Trial
Status: Enrolling
Updated:  4/1/2016
Univ of North Carolina
2194
mi
from 91732
Chapel Hill, NC
Study of Effectiveness and Safety of Azithromycin-based Extended-spectrum Prophylaxis to Prevent Post Cesarean Infection
Cesarean Section Optimal Antibiotic Prophylaxis Trial
Status: Enrolling
Updated: 4/1/2016
Univ of North Carolina
2194
mi
from 91732
Chapel Hill, NC
Click here to add this to my saved trials
Study of Effectiveness and Safety of Azithromycin-based Extended-spectrum Prophylaxis to Prevent Post Cesarean Infection
Cesarean Section Optimal Antibiotic Prophylaxis Trial
Status: Enrolling
Updated:  4/1/2016
University of Texas Medical Branch
1399
mi
from 91732
Galveston, TX
Study of Effectiveness and Safety of Azithromycin-based Extended-spectrum Prophylaxis to Prevent Post Cesarean Infection
Cesarean Section Optimal Antibiotic Prophylaxis Trial
Status: Enrolling
Updated: 4/1/2016
University of Texas Medical Branch
1399
mi
from 91732
Galveston, TX
Click here to add this to my saved trials
Study of Effectiveness and Safety of Azithromycin-based Extended-spectrum Prophylaxis to Prevent Post Cesarean Infection
Cesarean Section Optimal Antibiotic Prophylaxis Trial
Status: Enrolling
Updated:  4/1/2016
University of Texas Health Science Center at Houston
1352
mi
from 91732
Houston, TX
Study of Effectiveness and Safety of Azithromycin-based Extended-spectrum Prophylaxis to Prevent Post Cesarean Infection
Cesarean Section Optimal Antibiotic Prophylaxis Trial
Status: Enrolling
Updated: 4/1/2016
University of Texas Health Science Center at Houston
1352
mi
from 91732
Houston, TX
Click here to add this to my saved trials
Study of Effectiveness and Safety of Azithromycin-based Extended-spectrum Prophylaxis to Prevent Post Cesarean Infection
Cesarean Section Optimal Antibiotic Prophylaxis Trial
Status: Enrolling
Updated:  4/1/2016
University of Utah
572
mi
from 91732
Salt Lake City, UT
Study of Effectiveness and Safety of Azithromycin-based Extended-spectrum Prophylaxis to Prevent Post Cesarean Infection
Cesarean Section Optimal Antibiotic Prophylaxis Trial
Status: Enrolling
Updated: 4/1/2016
University of Utah
572
mi
from 91732
Salt Lake City, UT
Click here to add this to my saved trials
Study of Effectiveness and Safety of Azithromycin-based Extended-spectrum Prophylaxis to Prevent Post Cesarean Infection
Cesarean Section Optimal Antibiotic Prophylaxis Trial
Status: Enrolling
Updated:  4/1/2016
Ochsner Clinic Foundation
1650
mi
from 91732
New Orleans, LA
Study of Effectiveness and Safety of Azithromycin-based Extended-spectrum Prophylaxis to Prevent Post Cesarean Infection
Cesarean Section Optimal Antibiotic Prophylaxis Trial
Status: Enrolling
Updated: 4/1/2016
Ochsner Clinic Foundation
1650
mi
from 91732
New Orleans, LA
Click here to add this to my saved trials
Eltrombopag Olamine in Treating Patients With Relapsed/Refractory Acute Myeloid Leukemia
Phase I Dose-Finding Study of Eltrombopag Following High Dose Cytarabine and Mitoxantrone in Relapsed/Refractory Patients With Acute Myeloid Leukemia
Status: Enrolling
Updated:  4/4/2016
Roswell Park Cancer Institute
2181
mi
from 91732
Buffalo, NY
Eltrombopag Olamine in Treating Patients With Relapsed/Refractory Acute Myeloid Leukemia
Phase I Dose-Finding Study of Eltrombopag Following High Dose Cytarabine and Mitoxantrone in Relapsed/Refractory Patients With Acute Myeloid Leukemia
Status: Enrolling
Updated: 4/4/2016
Roswell Park Cancer Institute
2181
mi
from 91732
Buffalo, NY
Click here to add this to my saved trials
Eltrombopag Olamine in Treating Patients With Relapsed/Refractory Acute Myeloid Leukemia
Phase I Dose-Finding Study of Eltrombopag Following High Dose Cytarabine and Mitoxantrone in Relapsed/Refractory Patients With Acute Myeloid Leukemia
Status: Enrolling
Updated:  4/4/2016
Emory University/Winship Cancer Institute
1922
mi
from 91732
Atlanta, GA
Eltrombopag Olamine in Treating Patients With Relapsed/Refractory Acute Myeloid Leukemia
Phase I Dose-Finding Study of Eltrombopag Following High Dose Cytarabine and Mitoxantrone in Relapsed/Refractory Patients With Acute Myeloid Leukemia
Status: Enrolling
Updated: 4/4/2016
Emory University/Winship Cancer Institute
1922
mi
from 91732
Atlanta, GA
Click here to add this to my saved trials
Acupuncture for the Prevention of Postdates Pregnancy
A Randomized Controlled Trial of Acupuncture to Prevent Postdates Pregnancy
Status: Enrolling
Updated:  4/5/2016
UNC-Chapel Hill Family Medicine Center
2194
mi
from 91732
Chapel Hill, NC
Acupuncture for the Prevention of Postdates Pregnancy
A Randomized Controlled Trial of Acupuncture to Prevent Postdates Pregnancy
Status: Enrolling
Updated: 4/5/2016
UNC-Chapel Hill Family Medicine Center
2194
mi
from 91732
Chapel Hill, NC
Click here to add this to my saved trials
Phase I Combination of Midostaurin, Bortezomib, and Chemo in Relapsed/Refractory Acute Myeloid Leukemia
Phase I Study of the Combination of Midostaurin, Bortezomib, and Chemotherapy in Relapsed/Refractory Acute Myeloid Leukemia
Status: Enrolling
Updated:  4/5/2016
Ohio State University Medical Center
1959
mi
from 91732
Columbus, OH
Phase I Combination of Midostaurin, Bortezomib, and Chemo in Relapsed/Refractory Acute Myeloid Leukemia
Phase I Study of the Combination of Midostaurin, Bortezomib, and Chemotherapy in Relapsed/Refractory Acute Myeloid Leukemia
Status: Enrolling
Updated: 4/5/2016
Ohio State University Medical Center
1959
mi
from 91732
Columbus, OH
Click here to add this to my saved trials
Perimenopausal Estrogen Replacement Therapy Study
Depression, Estrogen Replacement, and Cardiovascular Health in the Perimenopause
Status: Enrolling
Updated:  4/6/2016
Univ of North Carolina
2194
mi
from 91732
Chapel Hill, NC
Perimenopausal Estrogen Replacement Therapy Study
Depression, Estrogen Replacement, and Cardiovascular Health in the Perimenopause
Status: Enrolling
Updated: 4/6/2016
Univ of North Carolina
2194
mi
from 91732
Chapel Hill, NC
Click here to add this to my saved trials
Permeability MRI in Cerebral Cavernous Malformations Type 1 in New Mexico: Effects of Statins
Permeability MRI in Cerebral Cavernous Malformations Type 1 in New Mexico: Effects of Statins
Status: Enrolling
Updated:  4/7/2016
University of New Mexico Health Sciences Center
648
mi
from 91732
Albuquerque, NM
Permeability MRI in Cerebral Cavernous Malformations Type 1 in New Mexico: Effects of Statins
Permeability MRI in Cerebral Cavernous Malformations Type 1 in New Mexico: Effects of Statins
Status: Enrolling
Updated: 4/7/2016
University of New Mexico Health Sciences Center
648
mi
from 91732
Albuquerque, NM
Click here to add this to my saved trials
Pharmacokinetics, Safety and Efficacy Study of Recombinant Antithrombin Versus Placebo in Preterm Preeclampsia
Prospective Randomized Double-Blind, Placebo Controlled Evaluation of the Pharmacokinetics, Safety and Efficacy of Recombinant Antithrombin Versus Placebo in Preterm Preeclampsia (PRESERVE-1)
Status: Enrolling
Updated:  4/8/2016
University of Alabama
1785
mi
from 91732
Birmingham, AL
Pharmacokinetics, Safety and Efficacy Study of Recombinant Antithrombin Versus Placebo in Preterm Preeclampsia
Prospective Randomized Double-Blind, Placebo Controlled Evaluation of the Pharmacokinetics, Safety and Efficacy of Recombinant Antithrombin Versus Placebo in Preterm Preeclampsia (PRESERVE-1)
Status: Enrolling
Updated: 4/8/2016
University of Alabama
1785
mi
from 91732
Birmingham, AL
Click here to add this to my saved trials
Pharmacokinetics, Safety and Efficacy Study of Recombinant Antithrombin Versus Placebo in Preterm Preeclampsia
Prospective Randomized Double-Blind, Placebo Controlled Evaluation of the Pharmacokinetics, Safety and Efficacy of Recombinant Antithrombin Versus Placebo in Preterm Preeclampsia (PRESERVE-1)
Status: Enrolling
Updated:  4/8/2016
University of South Alabama
1750
mi
from 91732
Mobile, AL
Pharmacokinetics, Safety and Efficacy Study of Recombinant Antithrombin Versus Placebo in Preterm Preeclampsia
Prospective Randomized Double-Blind, Placebo Controlled Evaluation of the Pharmacokinetics, Safety and Efficacy of Recombinant Antithrombin Versus Placebo in Preterm Preeclampsia (PRESERVE-1)
Status: Enrolling
Updated: 4/8/2016
University of South Alabama
1750
mi
from 91732
Mobile, AL
Click here to add this to my saved trials
Pharmacokinetics, Safety and Efficacy Study of Recombinant Antithrombin Versus Placebo in Preterm Preeclampsia
Prospective Randomized Double-Blind, Placebo Controlled Evaluation of the Pharmacokinetics, Safety and Efficacy of Recombinant Antithrombin Versus Placebo in Preterm Preeclampsia (PRESERVE-1)
Status: Enrolling
Updated:  4/8/2016
University of Arkansas
1463
mi
from 91732
Little Rock, AR
Pharmacokinetics, Safety and Efficacy Study of Recombinant Antithrombin Versus Placebo in Preterm Preeclampsia
Prospective Randomized Double-Blind, Placebo Controlled Evaluation of the Pharmacokinetics, Safety and Efficacy of Recombinant Antithrombin Versus Placebo in Preterm Preeclampsia (PRESERVE-1)
Status: Enrolling
Updated: 4/8/2016
University of Arkansas
1463
mi
from 91732
Little Rock, AR
Click here to add this to my saved trials
Pharmacokinetics, Safety and Efficacy Study of Recombinant Antithrombin Versus Placebo in Preterm Preeclampsia
Prospective Randomized Double-Blind, Placebo Controlled Evaluation of the Pharmacokinetics, Safety and Efficacy of Recombinant Antithrombin Versus Placebo in Preterm Preeclampsia (PRESERVE-1)
Status: Enrolling
Updated:  4/8/2016
The University of California Irvine
21
mi
from 91732
Orange, CA
Pharmacokinetics, Safety and Efficacy Study of Recombinant Antithrombin Versus Placebo in Preterm Preeclampsia
Prospective Randomized Double-Blind, Placebo Controlled Evaluation of the Pharmacokinetics, Safety and Efficacy of Recombinant Antithrombin Versus Placebo in Preterm Preeclampsia (PRESERVE-1)
Status: Enrolling
Updated: 4/8/2016
The University of California Irvine
21
mi
from 91732
Orange, CA
Click here to add this to my saved trials
Pharmacokinetics, Safety and Efficacy Study of Recombinant Antithrombin Versus Placebo in Preterm Preeclampsia
Prospective Randomized Double-Blind, Placebo Controlled Evaluation of the Pharmacokinetics, Safety and Efficacy of Recombinant Antithrombin Versus Placebo in Preterm Preeclampsia (PRESERVE-1)
Status: Enrolling
Updated:  4/8/2016
University of California San Francisco Medical Center
355
mi
from 91732
San Fransisco, CA
Pharmacokinetics, Safety and Efficacy Study of Recombinant Antithrombin Versus Placebo in Preterm Preeclampsia
Prospective Randomized Double-Blind, Placebo Controlled Evaluation of the Pharmacokinetics, Safety and Efficacy of Recombinant Antithrombin Versus Placebo in Preterm Preeclampsia (PRESERVE-1)
Status: Enrolling
Updated: 4/8/2016
University of California San Francisco Medical Center
355
mi
from 91732
San Fransisco, CA
Click here to add this to my saved trials
Pharmacokinetics, Safety and Efficacy Study of Recombinant Antithrombin Versus Placebo in Preterm Preeclampsia
Prospective Randomized Double-Blind, Placebo Controlled Evaluation of the Pharmacokinetics, Safety and Efficacy of Recombinant Antithrombin Versus Placebo in Preterm Preeclampsia (PRESERVE-1)
Status: Enrolling
Updated:  4/8/2016
Yale-New Haven Hospital
2486
mi
from 91732
New Haven, CT
Pharmacokinetics, Safety and Efficacy Study of Recombinant Antithrombin Versus Placebo in Preterm Preeclampsia
Prospective Randomized Double-Blind, Placebo Controlled Evaluation of the Pharmacokinetics, Safety and Efficacy of Recombinant Antithrombin Versus Placebo in Preterm Preeclampsia (PRESERVE-1)
Status: Enrolling
Updated: 4/8/2016
Yale-New Haven Hospital
2486
mi
from 91732
New Haven, CT
Click here to add this to my saved trials
Pharmacokinetics, Safety and Efficacy Study of Recombinant Antithrombin Versus Placebo in Preterm Preeclampsia
Prospective Randomized Double-Blind, Placebo Controlled Evaluation of the Pharmacokinetics, Safety and Efficacy of Recombinant Antithrombin Versus Placebo in Preterm Preeclampsia (PRESERVE-1)
Status: Enrolling
Updated:  4/8/2016
University of South Florida
2135
mi
from 91732
Tampa, FL
Pharmacokinetics, Safety and Efficacy Study of Recombinant Antithrombin Versus Placebo in Preterm Preeclampsia
Prospective Randomized Double-Blind, Placebo Controlled Evaluation of the Pharmacokinetics, Safety and Efficacy of Recombinant Antithrombin Versus Placebo in Preterm Preeclampsia (PRESERVE-1)
Status: Enrolling
Updated: 4/8/2016
University of South Florida
2135
mi
from 91732
Tampa, FL
Click here to add this to my saved trials